Clinical Trial Update: Immunogenicity nOPV2 With and Without bOPV [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity of the novel oral polio vaccine type 2 (nOPV2) with and without the bivalent OPV (bOPV); study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• bOPV (bivalent oral polio vaccine)
• nOPV2 (novel oral polio vaccine type 2)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Poliomyelitis | Phase 2 | Status: COMPLETED